Immune thrombocytopenia (ITP) trials in France

In France 18 Also abroad 118

18 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
Where
Antony, Creteil, Dijon, Pessac, Toulouse Cedex 9
Age
18 years and over
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07007962 · EU 2025-522070-36-00
Phase 1/2Taking people
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
Where
Creteil Cedex, Dijon, Pessac
Age
18 years to 64 years
People
68 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06721013 · EU 2024-518502-40-00
Phase 3Taking people
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Where
Creteil Cedex, Dijon
Age
18 years and over
People
171 worldwide
Run by
Takeda
See details and how to joinNCT06722235 · EU 2024-514401-54-00
Phase 1Taking people
Phase IB open label, long-term, extension basket trial of RAY121 to inhibit classical complement pathway in immunological diseases (RAINBOW-LTE trial)
Where
Montpellier Cedex 5, Paris
Age
18 years and over
People
78 worldwide
Run by
Chugai Pharmaceutical Co. Ltd.
See details and how to join2024-511346-39-00
Phase 3Taking people
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Where
Creteil, Dijon
Age
18 years and over
People
150 worldwide
Run by
Takeda
See details and how to joinNCT06948318 · EU 2025-521692-31-00
Phase 2Taking people
Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders
Where
Angers, Caen Cedex 9, Creteil Cedex, Dijon, Pessac, Toulouse, Vandoeuvre Les Nancy
Age
18 years and over
People
56 worldwide
Run by
Incyte Corporation
See details and how to joinNCT07104565 · EU 2025-521286-27-00
Phase 2/3Taking people
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
Where
Bordeaux, Grenoble Cedex 9, Nancy Cedex, Nantes
Age
12 years to 17 years
People
24 worldwide
Run by
argenx
See details and how to joinNCT07194850 · EU 2025-521055-23-00
Phase 1Taking people
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Where
Montpellier Cedex 5, Paris Cedex 13
Age
18 years to 85 years
People
144 worldwide
Run by
Chugai Pharmaceutical
See details and how to joinNCT06371417 · EU 2023-507692-21-00
Phase 1Enrolling by invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
Where
Montpellier, Paris
Age
18 years to 85 years
People
144 worldwide
Run by
Chugai Pharmaceutical
See details and how to joinNCT06723106
No phaseNot yet taking people in France
Modeling the Early Stages of Autoimmunity Through the Study of Immunological Thrombocytopenic Purpura and Juvenile Lupus
Where
Bordeaux, Toulouse
Age
1 year to 18 years
People
105
Run by
University Hospital, Bordeaux
See details and how to joinNCT07680010
No phaseTaking people
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
Where
Pessac
Age
18 years and over
People
225
Run by
University Hospital, Bordeaux
See details and how to joinNCT04800458
Phase 3Taking people
A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
Where
Amiens Cedex 1, Creteil, Dijon
Age
18 years and over
People
69 worldwide
Run by
argenx
See details and how to joinNCT06544499 · EU 2024-515451-38-00
No phaseTaking people
French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
Where
Toulouse
Age
18 years and over
People
1,500
Run by
University Hospital, Toulouse
See details and how to joinNCT02877706
No phaseNot yet taking people in France
Physical Fitness of Children, Adolescents and Young Adults With Immune Thrombocytopenic Purpura
Where
Montpellier, Palavas-les-Flots, Paris, Talence
Age
8 years to 25 years
People
53
Run by
University Hospital, Bordeaux
See details and how to joinNCT07310342
No phaseTaking people
Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia
Where
Pessac
Age
18 years and over
People
200
Run by
University Hospital, Bordeaux
See details and how to joinNCT04005638
No phaseTaking people
Observatory of Immunological Thrombopenic Purpura in the Brest Region
Where
Brest
People
500
Run by
University Hospital, Brest
See details and how to joinNCT06556888
Phase 3Taking people
Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia
Where
Amiens Cedex 1, Angers, Argenteuil Cedex, Avignon, Bois-Guillaume, Brest, Caen Cedex 9, Clamart, Clermont-Ferrand, Colmar Cedex, Corbeil-Essonnes, Creteil Cedex, Dijon, Dunkirk Cedex 1, La Roche Sur Yon Cedex 9, Le Kremlin-Bicetre, Lille Cedex, Lyon Cedex 04, Marseille, Nancy, Nantes, Paris, Paris Cedex 18, Périgueux, Pessac Cedex, Pierre-Bénite, Poitiers, Pringy Cedex, Quimper Cedex, Reims, Rennes, Saint Nazaire Cedex, Strasbourg Cedex, Suresnes, Toulouse
Age
18 years and over
People
132
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05338190 · EU 2024-516168-27-00
No phaseTaking people
OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia
Where
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Paris, Quimper
Age
Up to 17 years
People
3,500
Run by
University Hospital, Bordeaux
See details and how to joinNCT05937828